Company: IXHL
Filing Date: 2025-04-28
Form Type: 424B3
Source: 0001213900-25-036065
Chunk: 14

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-28
Form: 424B3
Chunk 14
---
 being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act and reduced
disclosure obligations regarding executive compensation. We will be able to take advantage of the scaled disclosures available to smaller
reporting companies for so long as our voting and non-voting common stock held by non-affiliates is less than $250.0 million measured
on the last business day of our second fiscal quarter, or our annual revenue is less than $100.0 million during the most recently completed
fiscal year and our voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business
day of our second fiscal quarter.

Additional Information

For additional information
related to our business and operations, please refer to the reports incorporated herein by reference, as described under the caption “Incorporation
of Certain Documents by Reference” on page 21 of this prospectus.

Corporate Information

Incannex Healthcare Inc.
was incorporated in Delaware in July 2023. On November 28, 2023, the redomiciliation of Incannex Healthcare Limited, an Australian corporation,
or Incannex Australia, was implemented under Australian law in accordance with the Scheme Implementation Deed, as amended and restated
on September 13, 2023, between Incannex Australia and the Company. As a result of the redomiciliation, Incannex Australia became a wholly-owned
subsidiary of Incannex Healthcare Inc.

Our principal office is located
at Suite 105, 8 Century Circuit Norwest, NSW 2153 Australia and our telephone number is +61 409 840 786. Our address on the Internet is
http://www.incannex.com. The reference to our website address does not constitute incorporation by reference of the information contained
at or available through our website, and you should not consider it to be a part of this prospectus.

The information on, or accessible
through, our website is not part of this prospectus. We file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports
on Form 8-K and amendments to those reports with SEC. Our filings with the SEC are available free of charge on the SEC’s website
and on the “Investors” section of our website as soon as reasonably practicable after we electronically file such material
with, or furnish it to, the SEC. The SEC maintains an internet site